Biodesix Inc (BDSX)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current BDSX market cap is 38.15M. The company's latest EPS is USD -0.2929 and P/E is -0.89.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 14.67M | 14.82M | 17.93M | 18.15M | 20.43M |
| Operating Income | -6.87M | -11.02M | -8.24M | -8.59M | -6.65M |
| Net Income | -9.14M | -13.61M | -10.81M | -10.26M | -8.25M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 45.56M | 54.51M | 38.21M | 49.09M | 71.32M |
| Operating Income | -22.93M | -40.94M | -50.59M | -41.34M | -34.5M |
| Net Income | -31.35M | -43.16M | -65.45M | -52.15M | -42.93M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 99.1M | 87.2M | 115.84M | 102.74M | 97.24M |
| Total Liabilities | 94.52M | 92.7M | 79.58M | 74.89M | 76.37M |
| Total Equity | 4.58M | -5.5M | 36.26M | 27.86M | 20.88M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 121.07M | 76.1M | 92.91M | 99.1M | 97.24M |
| Total Liabilities | 79.9M | 56.37M | 72.3M | 94.52M | 76.37M |
| Total Equity | 41.17M | 19.73M | 20.61M | 4.58M | 20.88M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -22.87M | -15.32M | -33.88M | -44.55M | -48.65M |
| Investing | -23.06M | -273k | -2.27M | -2.56M | -3.44M |
| Financing | 29.13M | 791k | 52.09M | 52.23M | 52.05M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -21.37M | -28.22M | -44.97M | -22.87M | -48.65M |
| Investing | -2.93M | -2.55M | -3.53M | -23.06M | -3.44M |
| Financing | 81.13M | 1.26M | 58.88M | 29.13M | 52.05M |
| Market Cap | 38.15M |
| Price to Earnings Ratio | -0.89 |
| Price to Sales Ratio | 0.53 |
| Price to Cash Ratio | 1.45 |
| Price to Book Ratio | 1.83 |
| Dividend Yield | - |
| Shares Outstanding | 146.56M |
| Average Volume (1 week) | 1.31M |
| Average Volume (1 Month) | 2.27M |
| 52 Week Change | -84.41% |
| 52 Week High | 2.04 |
| 52 Week Low | 0.1718 |
| Spread (Intraday) | 0 (0.31%) |
| Company Name | Biodesix Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.biodesix.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
